ANIXA BIOSCIENCES INC
ANIX Healthcare Biotechnology
ANIXA BIOSCIENCES INC’s revenue for fiscal 2023 (year ended October 2023) was $210,000.00. In the quarter to July 2026, EPS fell 14.3% and free cash flow fell 17.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ANIX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 | Oct '20 | Oct '19 | Oct '18 | Oct '17 | Oct '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
15.17 | 19.92 | 23.84 | 29.69 | 35.73 | 9.06 | 5.84 | 5.06 | 6.84 | 3.24 |
Receivables |
— | 0.17 | 0.27 | 0.05 | — | 0.00 | 0.07 | 0.31 | — | — |
Total current assets |
15.89 | 21.36 | 25.36 | 30.20 | 36.00 | 9.37 | 6.09 | 5.54 | 7.01 | 3.40 |
Property, Plant, Equpment (Net) |
— | — | — | — | — | — | 0.20 | 0.07 | 0.05 | 0.16 |
Goodwill and Intangible Assets (Total) |
— | — | — | — | — | — | — | 0.84 | 1.75 | 2.07 |
Long-term assets (Other) |
— | — | — | — | — | 0.03 | — | — | — | — |
Total non-current assets |
0.19 | 0.23 | 0.17 | 0.21 | 0.25 | 0.08 | 0.20 | 0.91 | 1.80 | 2.23 |
Total Assets |
16.08 | 21.59 | 25.52 | 30.41 | 36.26 | 9.45 | 6.29 | 6.45 | 8.81 | 5.63 |
Accounts Payable |
0.17 | 0.53 | 0.21 | 0.27 | 0.14 | 0.23 | 0.59 | 0.58 | 0.48 | 0.37 |
Accrued Expenses |
1.76 | 1.95 | 1.77 | 1.73 | 1.10 | 0.90 | 0.90 | 0.68 | 0.41 | 0.10 |
Total current liabilities |
1.97 | 2.50 | 2.03 | 2.04 | 1.27 | 1.19 | 1.48 | 1.27 | 0.89 | 0.47 |
Non-current Liabilities (Other) |
— | — | — | — | — | — | — | — | — | 4.17 |
Total non-current liabilities |
0.16 | 0.20 | 0.12 | 0.18 | 0.22 | — | — | — | — | 4.17 |
Total liabilities |
2.13 | 2.70 | 2.15 | 2.21 | 1.49 | 1.19 | 1.48 | 1.27 | 0.89 | 4.64 |
Additional Paid In Capital |
266.51 | 260.43 | 252.22 | 247.12 | 239.93 | 200.35 | 186.85 | 175.42 | 163.93 | 152.05 |
Preferred Stock (Total) |
— | — | — | — | — | — | — | — | — | 0.01 |
Common Stock (Net) |
0.33 | 0.32 | 0.31 | 0.31 | 0.30 | 0.24 | 0.20 | 0.19 | 0.17 | 0.09 |
Retained Earnings |
(251.68) | (240.75) | (228.20) | (218.38) | (204.79) | (191.84) | (181.82) | (170.17) | (156.17) | (151.17) |
Treasury Stock |
— | 0.01 | — | — | — | — | — | — | — | — |
Shareholders Equity (Other) |
(1.21) | (1.11) | (0.97) | (0.85) | (0.67) | (0.50) | (0.42) | (0.25) | — | — |
Common Equity (Total) |
13.95 | 18.89 | 23.37 | 28.20 | 34.77 | 8.26 | 4.81 | 5.18 | 7.92 | 0.97 |
Shareholders Equity (Total) |
13.95 | 18.89 | 23.37 | 28.20 | 34.77 | 8.26 | 4.81 | 5.18 | 7.92 | 0.99 |
Shareholders Equity and Liabilities (Total) |
16.08 | 21.59 | 25.52 | 30.41 | 36.26 | 9.45 | 6.29 | 6.45 | 8.81 | 5.63 |
Shares (Common) |
33.01 | 32.20 | 31.15 | 30.91 | 30.05 | 24.25 | 20.33 | 18.91 | 16.60 | 8.75 |
Shares (Preferred) |
— | — | — | — | — | — | — | — | — | 0.00 |
Shareholders Equity (Tangible) |
13.95 | 18.89 | 23.37 | 28.20 | 34.77 | 8.26 | 4.81 | 4.35 | 6.18 | (1.08) |
Net Debt |
(15.17) | (19.92) | (23.84) | (29.69) | (35.73) | (9.06) | (5.84) | (5.06) | (6.84) | (3.24) |
Total Debt |
— | — | — | 0.22 | 0.26 | 0.06 | — | — | — | 4.17 |